RNS Number : 5211V
Schroder Eur Real Est Inv Trust PLC
03 February 2025
 

3 February 2025

 

SCHRODER EUROPEAN REAL ESTATE INVESTMENT TRUST PLC

("SEREIT" or the "Company" and, together with its subsidiaries, the "Group")

 

Sale of Seville shopping centre interest reduces portfolio gearing to 21%

 

Schroder European Real Estate Investment Trust Plc, the Company investing in European growth cities, has announced the sale of its 50% interest in the Metromar Joint Venture, which owns a shopping centre in Seville, Spain. The disposal price is in line with the Company's previous recognition of its interest being nil value, with the outstanding debt transferring to the purchaser.

 

This sale strengthens the Company's balance sheet by reducing its net loan-to-value (LTV) ratio from 25% to 21%1.

 

Additionally, the previously announced sale of a grocery anchored retail asset in Frankfurt for €11.8 million, which is expected to complete on 31 March 2025, along with a repayment of associated bank debt, is expected to further decrease the net LTV by at least an additional 2%.

 

1​Based on 31 December 2024 independent valuations.

 

 

-Ends-

 

Enquiries:

Jeff O'Dwyer

Schroder Real Estate Investment Management Limited                              Tel: 020 7658 6000

Natalia de Sousa

Schroder Investment Management Limited                                                 Tel: 020 7658 6000

Dido Laurimore/Richard Gotla/Ollie Parsons

FTI Consulting                                                                                              Tel: 020 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEASFFDLASEFA